 |
A New Generation of Gene-editing Tools is Undergoing Trials, Part 2
Keywords:
The disorder, which affects one in 250 people, results in reduced clearance of bad cholesterol from the blood.
The treatment, VERVE-101, made by Verve Therapeutics, turns off the PCSK9 gene in the ...
每250人中就有1人患这种病,会导致血液中坏胆固醇的清除率降低。由Verve Therapeutics研发的这种治疗方法是VERVE-101,它通过对DNA进行单字母改变(从A变为G)来关闭肝脏中的PCSK9基因。
总部位于马萨诸塞州...
|